Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. is dated August 22, 2019, covering the month of August 2019. The filing serves as a notice regarding a special general meeting of shareholders scheduled for September 26, 2019, at the company's offices in Rehovot, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on corporate governance procedures related to the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors. It references the availability of a Proxy Statement (Exhibit 99.2) and Notice of the Meeting (Exhibit 99.1) on the company's website, which typically contain details on matters to be voted upon, but the content of those exhibits is not included in this text.
Key Facts for Investors to Verify
- Verify the specific agenda items and proposals to be voted on at the special general meeting by reviewing the Proxy Statement (Exhibit 99.2) on the company's investor relations website.
- Confirm the record date for shareholder eligibility to vote, which is not stated in this summary text.
- Check for any subsequent filings that may provide financial updates, as this Form 6-K contains no financial data.